Population
Vascular smooth muscle cells (VSMC A-10)
Comparison
Angiotensin II pretreatment, with or without… vs Control vascular smooth muscle cells
Design
Preclinical
Authors
Loading...
Hypothesis-generating for PKC-mediated ANF-R2 uncoupling in VSMCs; leaves open human relevance and therapeutic translation.
Angiotensin II modulates ANF-R2 receptor-mediated inhibition of adenylyl cyclase in vascular smooth muscle cells via PKC-mediated uncoupling from the Gi protein.
Anuradha Palaparti (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: